Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/26699
Type
ArticleCopyright
Open access
Embargo date
2019-01-01
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12978]
Metadata
Show full item record
DENGUE VIRUS SEROTYPE 2 ESTABLISHED IN NORTHERN MOZAMBIQUE (2015–2016)
Author
Affilliation
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Public Health Agency of Sweden. Solna, Sweden / Karolinska Institutet. Departmento of Laboratory Medicine. Stockholm, Sweden.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Public Health Agency of Sweden. Solna, Sweden / Karolinska Institutet. Department of Microbiology, Tumor and Cell Biology. Stockholm, Sweden.
Public Health Agency of Sweden. Solna, Sweden / Karolinska Institutet. Departmento of Laboratory Medicine. Stockholm, Sweden.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Flavivírus. Rio de Janeiro, RJ, Brasil.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Ministry of Health. National Institute of Health. Maputo, Mozambique.
Public Health Agency of Sweden. Solna, Sweden / Karolinska Institutet. Department of Microbiology, Tumor and Cell Biology. Stockholm, Sweden.
Abstract
After the report of an outbreak of dengue virus serotype 2 in 2014 in Nampula and Pemba cities, northern Mozambique, a surveillance system was established by the National Institute of Health. A study was performed during 2015–2016 to monitor the trend of the outbreak and confirm the circulating serotype of dengue virus (DENV). After the inclusionofconsentingpatientswhometthecasedefinition,samplesfrom192patientsweretestedforthepresenceof nonstructuralprotein1antigen,and60/192(31%)sampleswerepositive.FurtheranalysisincludedDENVIgMantibodies, with39(20%)IgMpositivecases.Reversetranscriptase(RT)PCRwasperformedforidentificationoftheprevailingDENV serotype; 21/23 tested samples were DENV-2 positive, with DENV-2 present in both affected cities. When sequencing DENV, phenotype Cosmopolitan was identified. The surveillance indicates ongoing spread of DENV-2 in northern Mozambique 2 years after the first report of the outbreak.
Share